Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Novel Targets in Drug Discovery' returned 532 results - Page 1 of 27   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing   GBI Research, Nov 2011, Pages: 143 GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing Summary GBI Research, the leading business intelligence provider, has released its latest research “GPCRs The Future of GPCRs in Drug Discovery: Novel Technologies, Leading Companies, and Opportunities for Target Expansion   Business Insights, April 2010, Pages: 130 of GPCRs in Drug Discovery: Novel Technologies, Leading Companies, and Opportunities for Target Expansion Innovations in Combating Infectious Diseases: Opportunities in Therapeutics and Diagnostics through Application of Proteomics, Genomics, Nanotechnology, and Novel Sources of Lead Generation   Business Insights, June 2010, Pages: 250 . Key features of this report This report presents a snapshot of how new technologies and approaches are being applied to the discovery of new drug targets, vaccine candidates, lead compounds, and novel Antimicrobial Drug Discovery   Future Medicine Ltd, June 2011, Pages: 104 antibacterials really work: impact on drug discovery Thomas Dick, Douglas Young - Are nonlethal targets useful for developing novel antimicrobials? José L Martínez, Fernando Rojo, Jordi Vila BULLETIN BOARD Lead Generation Strategies and Technologies in Drug Development - Emerging Techniques Such as Antisense Technology Will Allow Innovators to Minimize Costs   GBI Research, June 2011, Pages: 77 6.2 A Novel Technology to Enhance Fragment-Based Drug Discovery 53 6.2.1 ZoBio’s Target Immobilized NMR Spectroscopy Method for Fragment-Based Drugs 53 7 Pharmaceutical Outsourcing as a Strategy Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs   GBI Research, Feb 2010, Pages: 76 - Exploit M&A opportunities by identifying key market players with the most novel pipeline “Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Cost” provides an in-depth analysis Preclinical Models: Innovative Solutions to Accelerate Drug Discovery and Development   Business Insights, Feb 2010, Pages: 131 vertebrate, nonvertebrate, computer-based and imaging models that offer new perspectives and utility to aid the drug discovery and development process. This report explores novel preclinical models that show Antivirals: Novel Targets, Technologies, and Dealmaking   Decision Resources, Inc., Feb 2010, Pages: 32 development pipeline is robust and includes mainly HCV-specific antiviral agents. Which are the most promising classes for discovery and development of novel targeted HCV drugs? Which development compounds Drug Discovery in India and China - Gaining Momentum with Increasing Pressure on Cost Cutting   GBI Research, Feb 2010, Pages: 107 .1 GBI Research Report Guidance 3 Drug Discovery Process – Overview 3.1 Process of Early Preclinical Drug Discovery 3.1.1 Pre-discovery 3.1.2 Target Identification 3.1.3 Target Validation 3.1.4 Lead Principles of CNS Drug Development: From Test Tube to Patient   John Wiley and Sons Ltd, Jan 2010, Pages: 324 drug discovery, outlining the particular requirements and obstacles for CNS drugs - Addresses safety concerns and future drug targets - Provides succinct background information about the major CNS Innovative Technologies and Platforms: Fueling the Engines of Drug Discovery   Decision Resources, Inc., Nov 2011 candidates. Which companies are developing novel chemistry and computational technologies to support drug discovery efforts? What innovative biological platforms are supporting small-molecule discovery Antiviral Drugs: From Basic Discovery Through Clinical Trials   John Wiley and Sons Ltd, July 2011, Pages: 480 Inhibitors 1. Discovery and Development of Atazanavir Awny Farajallah, R. Todd Bunch, and Nicholas A. Meanwell 2. Discovery and Development of PL-100, A Novel HIV-1 Protease Inhibitor Jinzi J. Wu Nanobiotechnology Applications, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 772 Nanolasers for drug discovery Analysis of small molecule-protein interactions by nanowire biosensors Cells targeting by nanoparticles with attached small molecules Role of AFM for study of biomolecular Drug Delivery in Cancer - Technologies, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 639 discovery for cancer. Cancer drug delivery is no longer simply wrapping up cancer drugs in a new formulations for different routes of delivery. The focus is on targeted cancer therapy. The newer approaches Overview of the European Drug Discovery Market   Frost & Sullivan, Dec 2008, Pages: 98 development. Market Overview Scope for New Drug Targets Discovery in the Drug Discovery Industry Ridden with Challenges Rising costs, a limited drug pipeline and the impeding loss of patent coverage Successful Strategies for Drug Repositioning   Business Insights, April 2011, Pages: 101 technologies being used to identify new targets for molecules in companies' databases? - How does drug repositioning improve the intellectual property position of companies that employ this strategy? - What Proteomics - Technologies, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 607 discovery Oxford Genome Anatomy Project Proteins as drug targets Ligands to capture the purine binding proteome Chemical probes to interrogate key protein families for drug discovery Global proteomics Targeted Cancer Therapies: Novel Targets, Technologies, and Dealmaking   Decision Resources, Inc., Dec 2009, Pages: 39 The current flurry of research into the development of new drugs against novel cancer targets is unprecedented. Many pharmaceutical and biotech companies, drawn by the sustained success of approved Insights into Platform Technology and Early-Stage Pipeline Mergers and Acquisitions   Decision Resources, Inc., March 2009, Pages: 24 . - Therapeutic platforms: therapeutic antibodies, artificial protein scaffolds, RNAi therapeutics. - Target and lead discovery: RNAi technology, profiling drug efficacy, lead optimization, chemistries Fueling the Drug Discovery Engine: Biotech Investment and Business Trends   Decision Resources, Inc., June 2008, Pages: 50 new molecular entities (NMES) operate on novel targets or through new mechanisms of action? How have these drugs performed in the marketplace? What are the benefits and risks of developing first Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network